ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her state of practice after we conducted our analysis. The updated address appears on this page.

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,419Medicare Part D Prescriptions Filled, Including Refills
$502K Total Retail Price of All Prescriptions
442 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 427 371
METOPROLOL TARTRATE 337 306
SIMVASTATIN 326 290
AMLODIPINE BESYLATE 292 265
OMEPRAZOLE 247 218
FUROSEMIDE 236 231
LEVOTHYROXINE SODIUM 214 188
HYDROCHLOROTHIAZIDE 197 186
WARFARIN SODIUM 188 176
RANITIDINE HCL 169 154
GABAPENTIN 153 131
METFORMIN HCL 149 126
METOPROLOL SUCCINATE 149 132
LOVASTATIN 149 113
TRAZODONE HCL 147 120
LOSARTAN POTASSIUM 136 123
ATORVASTATIN CALCIUM 97 79
MIRTAZAPINE 95 95
LANTUS 95 76
DONEPEZIL HCL 94 93
PRAVASTATIN SODIUM 92 77
NAMENDA 91 91
CITALOPRAM HBR 91 77
RISPERIDONE 90 85
PREDNISONE 89 61
PANTOPRAZOLE SODIUM 88 76
LIDODERM 86 68
TRAMADOL HCL 83 72
ENALAPRIL MALEATE 82 63
SERTRALINE HCL 77 72
ATENOLOL 76 57
ALLOPURINOL 66 53
POTASSIUM CHLORIDE 63 59
FELODIPINE ER 63 55
ISOSORBIDE MONONITRATE ER 63 38
GEMFIBROZIL 63 55
KLOR-CON M20 61 59
FLUOXETINE HCL 60 50
TERAZOSIN HCL 57 45
OLANZAPINE 56 56
NEXIUM 55 38
POLYETHYLENE GLYCOL 3350 55 44
DIGOXIN 55 55
PAROXETINE HCL 53 52
AMITRIPTYLINE HCL 53 52 R
LANTUS SOLOSTAR 51 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.